
1æ¥7æé座ã人ããä»äºäžã«ã§ããå¥åº·ç¿æ £ãå šéšãŸãšãã
æã座ããæŒã座ããååŸããŸã座ããæ°ã¥ãã°å€æ¹ãå¯ãããããã¿ã
420åã
ãããæ¥æ¬äººã®1æ¥ã®åº§äœæéã ã20ãåœãæ¯ã¹ã調æ»ã§ã¯ã座ãæéãé·ã5ãåœã«å ¥ã£ãŠããããã¹ã¯ã¯ãŒã«ãŒãªãããã軜ãè¶ ããŠ8æéã10æéã¯ãããèªåã®å€æ¥ã«ããæ¯æãžã è¡ã£ãŠããã§å€§äžå€«ã§ãããšããæ£è ããããããããããã©ãæè¿ã®ç ç©¶ãèŠãŠãããšããã®ã倧äžå€«ãããšãã§ããªãæªãããªã£ãŠããŠããã
ååã§ã¯ã座äœ8æéã®å£ããéåã§åž³æ¶ãã¯ã©ããŸã§æ¬åœããã1æ¥3åã§æ»äº¡ãªã¹ã¯ã4å²äœãã£ãVILPAããææ°ã®ããŒã¿ã§ç޹ä»ãããåŸåã®ææããŒãã§ã¯ããããä»äºäžã«å ·äœçã«äœãã©ãããã°ãããããèªåãå®éã«ãã£ãŠãã1æ¥ã®ã¹ã±ãžã¥ãŒã«ãå«ããŠå šéšæžããã
座äœ8æéãè¶ ãããšã1æéããšã«ãªã¹ã¯ãç©ã¿äžãããïŒåº§ãããã®å¥åº·ãªã¹ã¯ïŒ
2018幎ã«åºãçŽ133äžäººã®ã¡ã¿è§£æïŒ34ç ç©¶ã®çµ±åïŒãããã座äœè¡åã®ç ç©¶ãšããŠã¯å€§èŠæš¡ãªãã®ã ã座ãããããšã©ããããå¥åº·ã«æªãã®ãïŒ
1æ¥ã®åº§äœæéã8æéãè¶ ãããšããããã1æéå¢ããããšã«å šæ»äº¡ãªã¹ã¯ãçŽ4%ãã€äžããã8æéæªæºã§ã¯ã»ãŒæšªã°ããã€ãŸãã8æéãã«ã²ãšã€å£ãããã
å¿è¡ç®¡ç³»ã®æ»äº¡ãªã¹ã¯ã¯ãã£ãšã·ãã¢ã§ãç®å®ã¯çŽ6æéããã以éã¯åãã1æéããã4%ãã€ç©ã¿äžãã£ãŠããã
ããã ãã ãšããµãŒããã§çµãããããããªãã
ããæ°ãã2024幎ã®JAMA Network Openã«åºãç ç©¶ïŒçŽ48äžäººã远跡12.85幎ïŒãããå°ãçã ãããäž»ã«åº§ã£ãŠä»äºãããŠãã人ã¯ãããã§ãªãäººãšæ¯ã¹ãŠå šæ»äº¡ãªã¹ã¯ã16%é«ããå¿è¡ç®¡æ»äº¡ãªã¹ã¯ã¯34%é«ãã£ãã
ãã ããããããããœãªã®ã ãã©ãã座ã£ããç«ã£ããã亀äºã«ãã£ãŠãããåŽåè ã§ã¯ããªã¹ã¯ã®äžä¹ããèŠãããªãã£ãïŒHR1.01ïŒã座äœã®ãç·éããããããšãªããããã¿ãŒã³ãã€ãŸãã©ãã ãäžæãæãã§ããããé¢ä¿ããŠãããã ã
2025幎ã«ã¯ç±³åœå¿èç åŠäŒã®åŠè¡èªã«ãçŽ9äžäººã®åº§äœæéãå é床èšã§å®¢èгçã«æž¬å®ããããŒã¿ãèŒã£ãã1æ¥10.6æé以äžåº§ã£ãŠãã人ã¯å¿äžå šãªã¹ã¯ã45%å¢ãå¿è¡ç®¡æ»äº¡ã62%å¢ã

äœããŸããããšãããšããã®ãªã¹ã¯äžæã¯ãé±150å以äžãšããéåã¬ã€ãã©ã€ã³ãæºãããŠãã人ã§ãã軜æžã¯ããããã®ã®æ®ã£ãŠãããšããããšã ã
ãžã ã«è¡ã£ãŠãããã倧äžå€«ããšã¯èšããªãã
ãéåã§åž³æ¶ããã¯ã©ããŸã§æ¬åœã
ãããéåã¯ç¡æå³ãªã®ããšãããšãããã§ããªãã話ã¯ããã¡ãã£ãšè€éã ã
2016幎ã«The Lancetã«åºã100äžäººè¶ ã®ã¡ã¿è§£æã§ã¯ã1æ¥60ã75åã®äžåŒ·åºŠéåãããŠãã人ã§é·æé座äœã«ããæ»äº¡ãªã¹ã¯å¢å ãã»ãŒæ¶ããŠããïŒHR1.04ïŒããã ããã¬ã€ãã©ã€ã³ã§æšå¥šããã30å/æ¥ã§ã¯è¶³ããªãã£ãã
2023幎ã«ã¯4ã€ã®å€§èŠæš¡è¿œè·¡ç ç©¶ãçµ±åããè§£æã§ãããå°ãå®çšçãªã©ã€ã³ã瀺ãããŠãããåº§äœæéãæ»äº¡ãªã¹ã¯ã«é¢é£ããŠããã®ã¯ã1æ¥ã®äžé«åŒ·åºŠã®éåïŒMVPAïŒã22åæªæºã®äººã ãã ã£ãã22å以äžã®äººã§ã¯ã座ãæéãé·ããŠãæ»äº¡ãªã¹ã¯ã®äžä¹ãã¯èŠãããªãã£ãã
22åããããªãçŸå®çã ã
ãã ãå è¿°ã®çŽ9äžäººã®ç ç©¶ã瀺ããããã«ãå¿äžå šãå¿è¡ç®¡æ»äº¡ã®ãªã¹ã¯ã ãã¯éåã§å®å šã«ã¯æ¶ããªããããã¯æ¥äžã«ããŸãã«åãããšâåŸã§åºãŠããã座äœäžæãâãåãããŠèãããã
ãŸãšãããšïŒ
âïž 1æ¥22åã®äžé«åŒ·åºŠã®éåãæäœã©ã€ã³ïŒåº§äœã®æ»äº¡ãªã¹ã¯ãã»ãŒäžåïŒ
âïž 1æ¥60ã75åã®äžåŒ·åºŠéåã§ã»ãŒå®å šã«çžæ®º
âïž å¿äžå šã»å¿è¡ç®¡æ»äº¡ã®ãªã¹ã¯ã¯éåã ãã§ã¯æ¶ããªã
ãâæ¥äžã®åº§äœäžæãåãããŠ
VILPAïŒ1æ¥3åã®äººã¯æ»äº¡ãªã¹ã¯ã4å²äœãã£ãïŒé«åŒ·åºŠã®ç掻掻åïŒ
èªåããã®1幎ã§ãã¡ã°ãæ£è ããã«è©±ããŠããæŠå¿µãããã ã
VILPAïŒVigorous Intermittent Lifestyle Physical ActivityïŒãéæ®µãéãäžããé§ ãŸã§æ©æ©ããããéãè·ç©ãéã¶ããžã ãããªããæ¥åžžã®äžã§æ¯ãäžããå Žé¢ããããŠäœããããã ãã
2022幎ã®Nature Medicineã®ç ç©¶ïŒééåè çŽ25,000人ïŒã§ã¯ã1æ¥ãã£ã3åãå1ã2åã®é«åŒ·åºŠæŽ»åããã£ãŠãã人ã¯å šæ»äº¡ãªã¹ã¯ã38ã40%ãå¿è¡ç®¡æ»äº¡ã48ã49%äœãã£ããããã¯å®æçã«ãžã ã«éã62,000人以äžã®çŸ€ãšåçã®å¹æéã ã
2025幎ã®Nature Communicationsã§ã¯ãé«åŒ·åºŠã®æŽ»å1åã¯å šæ»äº¡ãªã¹ã¯ã«ãããŠäžåŒ·åºŠ4.1åã«çžåœããå¿è¡ç®¡æ»äº¡ã§ã¯7.8åã«çžåœãããšããæç®ãåºãŠãããVILPAã«ã€ããŠã¯ä»¥åã®noteã§è©³ããæžããã®ã§ãã¡ã«ããºã ãå ·äœçãªããæ¹ã¯ãã¡ããèªãã§ã»ããã
ã²ãšã€ã ãè£è¶³ããŠãããšãããã§æããVILPAã®ç ç©¶ã¯ãã©ã¡ããUK Biobankç±æ¥ã®èгå¯ç ç©¶ãªã®ã§ãå æãæå®ããæ®µéã§ã¯ãªãããã ãè€æ°ã®ã¢ãŠãã«ã ã§äžè²«ããçµæãåºãŠããŠããã€æ¥åžžåäœã®åŒ·åºŠãäžããã ããªã®ã§å§ããããããããªãçç±ã¯ãªããšæã£ãŠããããªããå¿èãè èã®ç æ°ã»ç³å°¿ç ããã人ããèžã®çã¿ãªã©ã®çç¶ããã人ã¯ãæ¯ãäžããåããå§ããåã«äž»æ²»å»ã«çžè«ããŠã»ããã

30åããšã«5åæ©ãããããçŸæç¹ã®ãã¹ããããã³ã«ïŒåº§äœäžæã®æé©è§£ïŒ
ã³ãã³ãã¢å€§åŠã2023幎ã«åºããæ¯èŒè©Šéšã¯ãå°èŠæš¡ãªããæ¯ã¹æ¹ããããã ã£ããå¥åžžæäºº11åïŒ40ã60æ³ïŒã«8æé座ãç¶ããŠãããã5ã€ã®æ©è¡ãã¿ãŒã³ãæ¯èŒããŠããã
ã»30åããšã«1å
ã»60åããšã«1å
ã»30åããšã«5å
ã»60åããšã«5å
ã»åº§ãã£ã±ãªã
çµæïŒ
30åããšã«5åã®è»œãæ©è¡ã ãããè¡ç³ãšè¡å§ã®äž¡æ¹ãææã«æ¹åããã
é£åŸã®è¡ç³ã¹ãã€ã¯ã¯åº§ãã£ã±ãªããšæ¯ã¹ãŠå€§å¹
ã«æããããè¡å§ã¯4ã5mmHgäžãã£ãã

n=11ãšå°ããã®ã§ããã®1æ¬ã ãã§çµè«ãåºãã®ã¯å±ããããã ã2024幎ã®ãããã¯ãŒã¯ã¡ã¿è§£æã§ã30åééã®åº§äœäžæãæã广çãšè©äŸ¡ãããŠãããæ¹åæ§ã¯äžèŽããŠããã
2026幎ã®RCTïŒåº§äœãªãã£ã¹ã¯ãŒã«ãŒ86åã12é±éïŒã§ã¯ã1æéããšã«3åã®ãã€ã¯ãéåäŒæ©ã§ç©ºè ¹æè¡ç³ãçŽ5.6mg/dLäœäžãããŠãšã¹ãã2.1cmæžã£ããæ±ºããäŒæ©ãããªããå²åã¯å¹³å82%ã§ãçŸå®ã®è·å Žã§ãç¶ãããããšããããšã瀺ãããŠããã
ã¹ã¿ã³ãã£ã³ã°ãã¹ã¯ãæ®å¿µãªãç¥ãã
ã¹ã¿ã³ãã£ã³ã°ãã¹ã¯ã¯ã代è¬ã®åé¡ã解決ããªãã
ð© ããããå ã¯ã¡ã³ããŒã·ããéå®ã§ããæé¡1000åã§å šèšäºèªã¿æŸé¡ãåããªãã£ããããè§£çŽã§ããŸãã